These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15553227)

  • 1. Influence of spinline stress on release properties of a coaxial controlled release device based on EVA polymers.
    van Laarhoven H; Veurink J; Kruft MA; Vromans H
    Pharm Res; 2004 Oct; 21(10):1811-7. PubMed ID: 15553227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of supersaturation and crystallization phenomena on the release properties of a controlled release device based on EVA copolymer.
    van Laarhoven JA; Kruft MA; Vromans H
    J Control Release; 2002 Aug; 82(2-3):309-17. PubMed ID: 12175745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.
    Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K
    Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems.
    Schneider C; Langer R; Loveday D; Hair D
    J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring.
    van Laarhoven JA; Kruft MA; Vromans H
    Int J Pharm; 2002 Jan; 232(1-2):163-73. PubMed ID: 11790500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the feasibility of temperature-controlled accelerated drug release testing for an intravaginal ring.
    Externbrink A; Clark MR; Friend DR; Klein S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):966-73. PubMed ID: 23791685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
    Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations.
    Almeida A; Saerens L; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Dec; 439(1-2):223-9. PubMed ID: 23018111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer.
    Kalachandra S; Takamata T; Lin DM; Snyder EA; Webster-Cyriaque J
    J Mater Sci Mater Med; 2006 Dec; 17(12):1227-36. PubMed ID: 17143753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
    Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
    Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices.
    Genina N; Holländer J; Jukarainen H; Mäkilä E; Salonen J; Sandler N
    Eur J Pharm Sci; 2016 Jul; 90():53-63. PubMed ID: 26545484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of 5-fluorouridine from radiation-crosslinked poly(ethylene-co-vinyl acetate) films.
    de Queiroz AA; Abraham GA; Higa OZ
    Acta Biomater; 2006 Nov; 2(6):641-50. PubMed ID: 16876492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Cellulose Membrane to Eliminate Burst Release from Intravaginal Rings.
    Helbling IM; Ibarra JC; Luna JA
    AAPS J; 2016 Jul; 18(4):960-71. PubMed ID: 27097635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.